Clinical Features and Treatment Outcome of Carcinomatous Pericarditis due to Lung Cancer.
Y. Kida (Kobe, Japan), Y. Inui (Kobe, Japan), K. Sato (Kobe, Japan), R. Koketsu (Kobe, Japan), T. Sakurai (Kobe, Japan), K. Tada (Kobe, Japan), A. Ikeda (Kobe, Japan), K. Hashimoto (Kobe, Japan), N. Katakami (Kobe, Japan)
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Session: Lung cancer: modern therapies and beyond
Session type: Thematic Poster
Number: 2818
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kida (Kobe, Japan), Y. Inui (Kobe, Japan), K. Sato (Kobe, Japan), R. Koketsu (Kobe, Japan), T. Sakurai (Kobe, Japan), K. Tada (Kobe, Japan), A. Ikeda (Kobe, Japan), K. Hashimoto (Kobe, Japan), N. Katakami (Kobe, Japan). Clinical Features and Treatment Outcome of Carcinomatous Pericarditis due to Lung Cancer.. 2818
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: